Skip to main content

#154455

TERT/p16-Human Tonsillar Epithelial cell line

Cat. #154455

TERT/p16-Human Tonsillar Epithelial cell line

Cat. #: 154455

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Tonsil

Disease: Cancer

Model: Immortalised non-cancerous cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Aloysius Klingelhutz

Institute: The University of Iowa

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: TERT/p16-Human Tonsillar Epithelial cell line
  • Cancer: Head and neck cancer
  • Cancers detailed: Tonsillar Cell Transformation
  • Research fields: Cancer
  • Organism: Human
  • Tissue: Tonsil
  • Disease: Cancer
  • Growth properties: human tonsillar epithelial cells; Retains normal growth responses.
  • Model: Immortalised non-cancerous cell line
  • Conditional: No
  • Description: Used for studies to understand tonsillar cell transformation
  • Production details: Immortalized with TERT/p16 shRNA

Target Details

  • Target: Used for studies to understand tonsillar cell transformation

Handling

  • Format: Frozen
  • Growth medium: Keratinocyte serum free media supplemented with 0.16 ng/ml EGF and 25 μg/ml Bovine Pituitary Extract
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

References

  • Kimple et al. 2013. Cancer Res. 73(15):4791-800. PMID: 23749640.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.